Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology
Free Medical Books

  Ovarian Neoplasms

  Free Subscription


06.02.2012

1 Ann Oncol
3 BMC Cancer
2 Br J Cancer
1 Cancer Lett
1 Cancer Res
8 Gynecol Oncol
1 Int J Cancer
2 Nat Med
2 Oncol Rep


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Oncol

  1. BRUNDAGE M , Gropp M, Mefti F, Mann K, et al
    Health-related quality of life in recurrent platinum-sensitive ovarian cancer--results from the CALYPSO trial.
    Ann Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available



    BMC Cancer

  2. GAO Y , Liu Z, Chen X, Luo W, et al
    Intraoperative radiotherapy electron boost in advanced and recurrent epithelial ovarian carcinoma: a retrospective study.
    BMC Cancer. 2011;11:439.
    PubMed     Text format     Related articles    Abstract available


  3. SERNBO S , Gustavsson E, Brennan DJ, Gallagher WM, et al
    The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation.
    BMC Cancer. 2011;11:405.
    PubMed     Text format     Related articles    Abstract available


  4. SINGH PP , Joshi S, Russell PJ, Nair S, et al
    Purine Nucleoside Phosphorylase mediated molecular chemotherapy and conventional chemotherapy: a tangible union against chemoresistant cancer.
    BMC Cancer. 2011;11:368.
    PubMed     Text format     Related articles    Abstract available



    Br J Cancer

  5. PARKIN DM
    15. Cancers attributable to reproductive factors in the UK in 2010.
    Br J Cancer. 2011;105 Suppl 2:S73-6.
    PubMed     Text format     Related articles   


  6. PARKIN DM
    10. Cancers attributable to exposure to hormones in the UK in 2010.
    Br J Cancer. 2011;105 Suppl 2:S42-8.
    PubMed     Text format     Related articles   



    Cancer Lett

  7. YANG X , Wang J, Zhou Y, Wang Y, et al
    Hsp70 promotes chemoresistance by blocking Bax mitochondrial translocation in ovarian cancer cells.
    Cancer Lett. 2012.
    PubMed     Text format     Related articles    Abstract available



    Cancer Res

  8. WHITE KL , Schildkraut JM, Palmieri RT, Iversen ES, et al
    Ovarian Cancer Risk Associated with Inherited Inflammation-Related Variants.
    Cancer Res. 2012.
    PubMed     Text format     Related articles    Abstract available



    Gynecol Oncol

  9. SONG T , Choi CH, Cho YJ, Sung CO, et al
    Expression of 67-kDa laminin receptor was associated with tumor progression and poor prognosis in epithelial ovarian cancer.
    Gynecol Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available


  10. MUTCH DG
    The more things change the more they stay the same.
    Gynecol Oncol. 2012;124:3-4.
    PubMed     Text format     Related articles   


  11. GUNTUPALLI SR , Zighelboim I, Kizer NT, Zhang Q, et al
    Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available


  12. ALTUNTAS CZ , Jaini R, Kesaraju P, Jane-Wit D, et al
    Autoimmune mediated regulation of ovarian tumor growth.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available


  13. ROMERO IL , Lee W, Mitra AK, Gordon IO, et al
    The effects of 17beta-estradiol and a selective estrogen receptor modulator, bazedoxifene, on ovarian carcinogenesis.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available


  14. BRUNNER A , Hinterholzer S, Riss P, Heinze G, et al
    Immunoexpression of B7-H3 in endometrial cancer: Relation to tumor T-cell infiltration and prognosis.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available


  15. CHI DS , Musa F, Dao F, Zivanovic O, et al
    An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT).
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available


  16. VOSS MA , Ganesan R, Ludeman L, McCarthy K, et al
    Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer-A clinical and pathological evaluation.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



    Int J Cancer

  17. HORIUCHI A , Hayashi T, Kikuchi N, Hayashi A, et al
    Hypoxia upregulates ovarian cancer invasiveness via the binding of HIF-1alpha to a hypoxia-induced, methylation free hypoxia response element (HRE) of S100A4 gene.
    Int J Cancer. 2012 Jan 27. doi: 10.1002/ijc.27448.
    PubMed     Text format     Related articles    Abstract available



    Nat Med

  18. WIEMER EA
    Stressed tumor cell, chemosensitized cancer.
    Nat Med. 2011;17:1552-4.
    PubMed     Text format     Related articles   


  19. MATEESCU B , Batista L, Cardon M, Gruosso T, et al
    miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response.
    Nat Med. 2011;17:1627-35.
    PubMed     Text format     Related articles    Abstract available



    Oncol Rep

  20. CHEN P , Pang X, Zhang Y, He Y, et al
    Effect of inhibition of the adrenomedullin gene on the growth and chemosensitivity of ovarian cancer cells.
    Oncol Rep. 2012 Jan 26. doi: 10.3892/or.2012.1655.
    PubMed     Text format     Related articles    Abstract available


  21. ZHU J , Hua K, Sun H, Yu Y, et al
    Re-expression of estrogen receptor beta inhibits the proliferation and migration of ovarian clear cell adenocarcinoma cells.
    Oncol Rep. 2011;26:1497-503.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: